XENE
Xenon Pharmaceuticals Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -6.7% ·
aandelenstroom -7.9% ·
netto nieuwe posities -7.1%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | +7 | 55.64M | $3.35B | +11 | −4 |
| Q1 2026 | 110 | +12 | 59.13M | $3.41B | +18 | −6 |
| Q4 2025 | 96 | 0 | 51.65M | $2.31B | +1 | −1 |
| Q3 2025 | 17 | 0 | 29.02M | $1.17B | — | — |
| Q2 2025 | 14 | -1 | 23.81M | $745.12M | +1 | −2 |
| Q1 2025 | 12 | +1 | 10.74M | $360.22M | +1 | — |
| Q4 2024 | 11 | -1 | 10.24M | $401.45M | — | −1 |
| Q3 2024 | 11 | 0 | 11.68M | $459.86M | — | — |
| Q2 2024 | 11 | — | 11.68M | $455.36M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 8.88M | — | $278.08M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 8.88M | — | $278.08M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 8.88M | — | $278.08M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 2.17M | -42.6% | $68.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Wellington Management ✦ | 2.17M | -42.6% | $68.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Wellington Management ✦ | 2.17M | -42.6% | $68.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Wellington Management ✦ | 2.17M | -42.6% | $68.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 2.17M | -42.6% | $68.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (passief) | 1.38M | +351.7% | $43.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | Adage Capital Partners ✦ | 1.29M | -32.6% | $40.38M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 26 | Marshall Wace ✦ | 1.02M | +34.6% | $31.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passief) | 970.34K | +1294.2% | $30.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Geode Capital Management ✦ (passief) | 970.34K | +1294.2% | $30.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Millennium Management ✦ | 882.84K | +277.2% | $27.63M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | The Vanguard Group ✦ (passief) | 873.23K | — | $27.33M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | The Vanguard Group ✦ (passief) | 873.23K | — | $27.33M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | The Vanguard Group ✦ (passief) | 873.23K | — | $27.33M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | The Vanguard Group ✦ (passief) | 873.23K | — | $27.33M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | The Vanguard Group ✦ (passief) | 873.23K | — | $27.33M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Capital World Investors ✦ | 655.74K | -70.5% | $20.52M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | D. E. Shaw & Co. ✦ | 141.78K | -6.8% | $4.44M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Citadel Advisors ✦ | 120.05K | -82.5% | $3.76M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 37.94K | Nieuw | $1.19M | 0.0% | New | 1 | SEC ↗ |
| 39 | T. Rowe Price ✦ | 37.94K | Nieuw | $1.19M | 0.0% | New | 1 | SEC ↗ |
| 40 | Renaissance Technologies ✦ | 8.60K | -94.4% | $269,180 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| T. Rowe Price | $1.19M | 0.0% |
| T. Rowe Price | $1.19M | 0.0% |
Verlaten
| Two Sigma Investments | $7.95M | was 0.0% |
| Point72 Asset Management | $7.04M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 129.80K aandelen, $7,547 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 10.00K aand · $640,550
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie